home / stock / ipatf / ipatf quote
Last: | $18.70 |
---|---|
Change Percent: | 0.43% |
Open: | $18.8 |
Close: | $18.70 |
High: | $20.254 |
Low: | $17.7 |
Volume: | 63,314 |
Last Trade Date Time: | 12/29/2020 04:54:56 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.7 | $18.8 | $18.7 | $20.254 | $17.7 | 63,314 | 12-29-2020 |
$18.62 | $17 | $18.62 | $19.51 | $16.75 | 46,579 | 12-28-2020 |
$16.39 | $14.3191 | $16.39 | $16.98 | $14.3191 | 47,118 | 12-25-2020 |
$16.39 | $14.3191 | $16.39 | $16.98 | $14.3191 | 47,118 | 12-24-2020 |
$14.3 | $11.87 | $14.3 | $14.6896 | $11.75 | 72,804 | 12-23-2020 |
$11.3905 | $11.05 | $11.3905 | $11.45 | $10.71 | 14,782 | 12-22-2020 |
$11.0505 | $11.35 | $11.0505 | $11.35 | $10.7411 | 38,195 | 12-21-2020 |
$11.05 | $10.5757 | $11.05 | $11.06 | $10.36 | 22,436 | 12-18-2020 |
$1.2839 | $1.28 | $1.2839 | $1.29 | $1.24 | 78,534 | 11-20-2020 |
$1.2698 | $1.3073 | $1.2698 | $1.31 | $1.2556 | 134,506 | 11-19-2020 |
$1.2399 | $1.2399 | $1.2399 | $1.24 | $1.17 | 220,252 | 11-18-2020 |
$1.23 | $1.271623 | $1.23 | $1.2716 | $1.1805 | 98,551 | 11-17-2020 |
$1.27 | $1.3 | $1.27 | $1.36 | $1.234 | 113,692 | 11-16-2020 |
$1.3796 | $1.37487 | $1.3796 | $1.4189 | $1.3483 | 69,168 | 11-13-2020 |
$1.4109 | $1.46321 | $1.4109 | $1.49 | $1.3968 | 55,161 | 11-12-2020 |
$1.4517 | $1.49 | $1.4517 | $1.49 | $1.3717 | 86,008 | 11-11-2020 |
$1.42 | $1.2 | $1.42 | $1.44 | $1.2 | 168,810 | 11-10-2020 |
$1.27 | $1.5483 | $1.27 | $1.55 | $1.1601 | 534,518 | 11-09-2020 |
$1.5952 | $1.51 | $1.5952 | $1.65 | $1.51 | 54,154 | 11-06-2020 |
$1.58 | $1.700337 | $1.58 | $1.7003 | $1.57 | 77,786 | 11-05-2020 |
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...